altamiratherapeutics.com Open in urlscan Pro
168.119.41.54  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * About
   * Leadership Team
   * Board of Directors
 * Our Science
 * Our Programs
 * Our Products
 * Investors & Media

 * Contact us

 * About
    * Leadership Team
    * Board of Directors

 * Our Science
    * RNA Therapeutics
    * Viral Infections and Allergies
    * Inner Ear Therapeutics

 * Our Programs
    * RNA Therapeutics
    * Viral Infections and Allergies
    * Inner Ear Therapeutics

 * Our Products
    * Bentrio

 * Investors & Media
    * Overview
    * Events & Presentations
    * Corporate Governance
    * SEC Filings
    * Press Releases
    * Newsroom
    * Stock Information
    * Investor FAQs
    * Investor Contact
    * Email Alerts

 * Contact us





TARGETING UNMET
MEDICAL NEEDS

Altamira Therapeutics is dedicated to developing therapeutics that address
important unmet medical needs. The Company is currently active in RNA
therapeutics, allergy and viral infections, and inner ear disorders.

Learn more


TARGETING UNMET
MEDICAL NEEDS

Altamira Therapeutics is dedicated to developing therapeutics that address
important unmet medical needs. The Company is currently active in RNA
therapeutics, allergy and viral infections, and inner ear disorders.

Learn more


TARGETING UNMET
MEDICAL NEEDS

Altamira Therapeutics is dedicated to developing therapeutics that address
important unmet medical needs. The Company is currently active in RNA
therapeutics, allergy and viral infections, and inner ear disorders.

Learn more


TARGETING UNMET
MEDICAL NEEDS

Learn more
Auris Medical is dedicated to developing therapeutics that address important
unmet medical needs. The Company is currently active in RNA therapeutics,
allergy and viral infections, and inner ear disorders.



RNA therapeutics for
extrahepatic targets

Learn more

Medical devices for
protection against airborne
allergens and viruses

Learn more

Therapeutics for
inner ear disorders

Learn more



LATEST NEWS

View all


01|21

Altamira Therapeutics Announces Approval of Bentrio Nasal Spray in Malaysia

Read more


01|13

Altamira Therapeutics Provides Update on RNA Therapeutics Program

Read more


01|05

Altamira Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual
Conference

Read more




OUR SCIENCE

Learn more


OUR PROGRAMS

Learn more


OUR PRODUCTS

Learn more
 




OUR SCIENCE

Learn more


OUR PROGRAMS

Learn more


OUR PRODUCTS

Learn more
 

© Altamira Therapeutics 2022

Imprint  |  Privacy Notice  |  Terms of Use

hear@altamiratherapeutics.com



This website uses cookies. By clicking on the “Ok” button, you consent to our
use of cookies as described in our Privacy Notice.

Ok